Table 3 Major wound complications for lower extremities stratified by the timing of the treatment
|  | Neoadjuvant therapy (n = 24) | Adjuvant therapy (n = 15) | Significance |
|---|---|---|---|
Patients with MWC | 11 (45.8%) | 3 (20.0%) | p = 0.097 |
Total number of MWCs | 27 | 3 | Â |
  Wound healing disorder | 8 (33.3%) | 2 (13.3%) | p = 0.155 |
  Wound infection | 8 (33.3%) | 0 (0.0%) | p = 0.012 |
  Abscess | 2 (8.3%) | 0 (0.0%) | p = 0.372 |
  Postoperative seroma | 3 (12.5%) | 1 (6.7%) | p = 0.498 |
  Postoperative hematoma | 2 (8.3%) | 0 (0.0%) | p = 0.372 |
  Fistula | 4 (16.7%) | 0 (0.0%) | p = 0.129 |